![]() |
|
#1
|
|||
|
|||
|
(Reuters) - A U.S. appeals court has upheld drugmaker Shire's patents for its top-selling drug Vyvanse, blocking five generic drug makers from launching cheaper versions of the drug to treat attention deficit hyperactivity before 2023. ![]() ??????? ??????: U.S. appeals court upholds Shire?s patents on hyperactivity drug || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|